CLINICAL_TRIALS
trial_result
· 2012-03-08
Clinical Trial Update: Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM [Phase 3]
Summary
Phase 3 studies evaluated linagliptin as monotherapy and in combination for type 2 diabetes mellitus; results from the completed trial were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2012-03-08